Literature DB >> 1854630

Chemotherapy for metastatic soft tissue sarcomas--another full circle?

V H Bramwell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1854630      PMCID： PMC1977315          DOI： 10.1038/bjc.1991.230

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  33 in total

1.  Chromosomal changes in soft-tissue sarcomas. A new diagnostic parameter.

Authors:  C P Karakousis; P Dal Cin; C Turc-Carel; J Limon; A A Sandberg
Journal:  Arch Surg       Date:  1987-11

2.  Phase II study of a combination of mitomycin, doxorubicin and cisplatin in advanced sarcomas.

Authors:  J H Edmonson; H J Long; R L Richardson; E T Creagan; S J Green
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

Review 3.  Ifosfamide--pharmacology, safety and therapeutic potential.

Authors:  W P Brade; K Herdrich; M Varini
Journal:  Cancer Treat Rev       Date:  1985-03       Impact factor: 12.111

4.  Response to mesna, doxorubicin, ifosfamide, and dacarbazine in 108 patients with metastatic or unresectable sarcoma and no prior chemotherapy.

Authors:  A Elias; L Ryan; A Sulkes; J Collins; J Aisner; K H Antman
Journal:  J Clin Oncol       Date:  1989-09       Impact factor: 44.544

Review 5.  Current perspectives in the management of soft-tissue sarcoma. The role of chemotherapy in multimodality therapy.

Authors:  V H Bramwell
Journal:  Can J Surg       Date:  1988-11       Impact factor: 2.089

6.  Response to ifosfamide and mesna: 124 previously treated patients with metastatic or unresectable sarcoma.

Authors:  K H Antman; L Ryan; A Elias; D Sherman; H E Grier
Journal:  J Clin Oncol       Date:  1989-01       Impact factor: 44.544

7.  Combination chemotherapy (CYVADIC) in metastatic soft tissue sarcomas.

Authors:  C P Karakousis; U Rao; H C Park
Journal:  Eur J Cancer Clin Oncol       Date:  1982-01

8.  A phase II study of ifosfamide/mesna with doxorubicin for adult soft tissue sarcoma.

Authors:  B M Cantwell; J Carmichael; S Ghani; A L Harris
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

9.  Expression of c-sis and other cellular proto-oncogenes in human sarcoma cell lines and biopsies.

Authors:  C Fahrer; R Brachmann; K von der Helm
Journal:  Int J Cancer       Date:  1989-10-15       Impact factor: 7.396

10.  A comparison of adriamycin versus vincristine and adriamycin, and cyclophosphamide versus vincristine, actinomycin-D, and cyclophosphamide for advanced sarcoma.

Authors:  D A Schoenfeld; C Rosenbaum; J Horton; J M Wolter; G Falkson; R C DeConti
Journal:  Cancer       Date:  1982-12-15       Impact factor: 6.860
View more
  5 in total

Review 1.  Doxorubicin-based chemotherapy for the palliative treatment of adult patients with locally advanced or metastatic soft tissue sarcoma.

Authors:  V H C Bramwell; D Anderson; M L Charette
Journal:  Cochrane Database Syst Rev       Date:  2003

2.  Treatment of advanced, high-grade soft-tissue sarcoma with ifosfamide and continuous-infusion etoposide.

Authors:  G Saeter; K Talle; O P Solheim
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

3.  The treatment and outcome of patients with soft tissue sarcomas and synchronous metastases.

Authors:  John M Kane; J William Finley; Deborah Driscoll; William G Kraybill; John F Gibbs
Journal:  Sarcoma       Date:  2002

4.  Doxorubicin-based chemotherapy for the palliative treatment of adult patients with locally advanced or metastatic soft-tissue sarcoma: a meta-analysis and clinical practice guideline.

Authors:  V H Bramwell; D Anderson; M L Charette
Journal:  Sarcoma       Date:  2000

5.  A Phase II Study of Docetaxel in Chemotherapy-Naïve Patients With Recurrent or Metastatic Adult Soft Tissue Sarcoma.

Authors:  V Bramwell; M Blackstein; K Belanger; S Verma; S Beare; E Eisenhauer
Journal:  Sarcoma       Date:  1998
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.